Clinical Trial: Efficacy and Safety of Janus Kinase Inhibitors Versus Glucocorticoids in the Treatment of Progressive Vitiligo: An Exploratory, Prospective, Randomized Controlled Trial (China)

Posted On: 2026-11-04

China, Nov. 4 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of Janus Kinase Inhibitors Versus Glucocorticoids in the Treatment of Progressive Vitiligo: An Exploratory, Prospective, Randomized Controlled Trial'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135862

Registration Time: 2026/11/03

Type: Interventional study

Primary Sponsor: Huashan Hospital, Fudan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342967

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Efficacy and Safety of Janus Kinase Inhibitors Versus Glucocorticoids in the Treatment of Progressive Vitiligo: An Exploratory, Prospective, Randomized Controlled Trial (China)